Related Experiment Video

Updated: Jun 9, 2026

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells
09:32

Multiplexed Immunofluorescence Analysis and Quantification of Intratumoral PD-1+ Tim-3+ CD8+ T Cells

Published on: February 8, 2018

Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity

Kaori Sakuishi1, Lionel Apetoh, Jenna M Sullivan

  • 1Center for Neurological Diseases, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02115, USA.

The Journal of Experimental Medicine
|September 8, 2010
PubMed

Insights

Blocking both T cell immunoglobulin mucin (Tim) 3 and PD-1 pathways shows promise in enhancing anti-tumor immunity. Targeting these exhausted T cell markers can improve immune response against solid tumors.

Area of Science:

  • Immunology
  • Oncology
  • Cellular Biology

Background:

  • Immune suppression hinders anti-tumor responses.
  • T cell exhaustion is a key immunosuppressive mechanism.
  • PD-1 blockade partially restores T cell function.

Purpose of the Study:

  • Investigate T cell immunoglobulin mucin (Tim) 3 expression on tumor-infiltrating lymphocytes (TILs).
  • Determine the role of Tim-3 and PD-1 co-expression in T cell exhaustion.
  • Evaluate the efficacy of combined Tim-3 and PD-1 pathway targeting in controlling tumor growth.

Main Methods:

  • Analysis of CD8(+) TILs in mice bearing solid tumors.
  • Co-expression analysis of Tim-3 and PD-1 on TILs.
  • Assessment of T cell proliferation and cytokine production (IL-2, TNF, IFN-γ).
  • In vivo tumor growth control studies.

Main Results:

  • Tim-3 is expressed on CD8(+) TILs and co-expressed with PD-1.
  • Tim-3(+)PD-1(+) TILs exhibit a severely exhausted phenotype.
  • Combined targeting of Tim-3 and PD-1 pathways is superior to single-pathway targeting for tumor growth control.

Conclusions:

  • Tim-3 and PD-1 are co-expressed on highly exhausted TILs.
  • Combined blockade of Tim-3 and PD-1 pathways enhances anti-tumor immunity.
  • Dual targeting strategies offer a promising approach for cancer immunotherapy.

More Related Videos

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice07:36

Tumor Transplantation for Assessing the Dynamics of Tumor-Infiltrating CD8+ T Cells in Mice

Published on: June 12, 2021

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

Related Concept Videos

Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
The Tumor Microenvironment02:17

The Tumor Microenvironment

Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...